Alimera Sciences Aktien im Umlauf
Was ist das Aktien im Umlauf von Alimera Sciences?
Aktien im Umlauf von Alimera Sciences Inc. ist 54.384M
Was ist die Definition von Aktien im Umlauf?
Im Umlauf befindliche Aktien sind alle Aktien einer Gesellschaft oder eines finanziellen Vermögenswertes, die von Anlegern genehmigt, ausgegeben und gekauft wurden und von diesen gehalten werden.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Aktien im Umlauf von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Alimera Sciences
Was macht Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Unternehmen mit aktien im umlauf ähnlich Alimera Sciences
- Lindblad Expeditions Inc hat Aktien im Umlauf von 54.319M
- BelaraRox Ltd hat Aktien im Umlauf von 54.330M
- NP3 Fastigheter AB (publ) hat Aktien im Umlauf von 54.339M
- Blackline Safety hat Aktien im Umlauf von 54.349M
- IPL Plastics hat Aktien im Umlauf von 54.382M
- Sol Cuisine Ltd hat Aktien im Umlauf von 54.382M
- Alimera Sciences hat Aktien im Umlauf von 54.384M
- 827013 hat Aktien im Umlauf von 54.385M
- Veritex Inc hat Aktien im Umlauf von 54.386M
- Smith & Wesson Brands hat Aktien im Umlauf von 54.389M
- Kudelski SA hat Aktien im Umlauf von 54.390M
- Galera Therapeutics Inc hat Aktien im Umlauf von 54.392M
- PIMCO Corporate & Income Strategy Fund hat Aktien im Umlauf von 54.406M